An investment strategy for (a lack of) inflation?
9 mins. to read
Inflation expectations are on the rise, but what happens if those expectations fail to materialise?
Magazine
The best emerging markets funds to invest in now
9 mins. to read
If it continues as many expect, the recent emerging-markets revival could herald a third major period of EM outperformance.
Book Review: Technical Analysis and Stock Market Profits
4 mins. to read
Ahead of its 90th anniversary, Harriman House has re-released Technical Analysis as part of its Definitive edition series with a new foreword from commodity trader Peter L. Brandt. Richard Gill, CFA, reviews.
I am more and more convinced it’s time to buy UK Plc.
7 mins. to read
There is nothing we Brits like as much as talking ourselves down but has the negativity towards the UK’s prospects gone too far?
UK equity income poised for recovery?
10 mins. to read
With dividends being resumed and the vaccination programme well underway, British income stocks could be on the verge of a fast recovery.
Three European water ETFs to hydrate your portfolio
8 mins. to read
Filipe R. Costa explores the merits of investing in clean water through thematic ETFs.
Small cap income stocks perfect for your ISA
12 mins. to read
Richard Gill, CFA, reviews three companies he thinks could contribute significantly to both your ISA dividend income and capital growth over the next few years.
Stocks in Focus: Sareum Holdings
7 mins. to read
A developer of best-in-class targeted therapeutics has had its near- clinic ready TYK2/JAK 1 inhibitor programme earmarked as a potential therapy for severe Covid-19.
The Vaccinators – Some vaccine developers have fared better than others
15 mins. to read
Some pharmaceutical companies have managed to develop a coronavirus vaccine in record time, while others have given up.
Book review: When the Fund Stops
5 mins. to read
Richard Gill, CFA, reviews When the Fund Stops, the untold story behind the downfall of Neil Woodford, Britain’s most successful fund manager.